Resistance of muscle to tumor metastases: A role for A3 adenosine receptor agonists

Neoplasia

Volumn 3, Issue 2, 2001, Pages 125-131

  Bar Yehuda, S ^a   Barer, F ^a   Volfsson, L ^b   Fishman, P ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Can Fite BioPharma   (Israel)

Author keywords

A3 adenosine receptor; Agonists; Muscle; Tumor

Indexed keywords

1 DEOXY 1 [6 [[(3 IODOPHENYL)METHYL]AMINO] 9H PURINE 9 YL] N METHYL BETA DEXTRO RIBOFURANURONAMIDE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE DEAMINASE; ADENOSINE RECEPTOR STIMULATING AGENT; FURAN DERIVATIVE; G PROTEIN COUPLED RECEPTOR; MUSCLE CELL CONDITIONED MEDIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW TOXICITY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0035050529     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900138     Document Type: Article

References (30)

1. Intramyofiber metastasis in skeletal muscle
2. Carcinoma of the lung occurring as a skeletal muscle mass
3. Recurrent solitary metastasis of renal cell carcinoma in skeletal muscles
4. Growth factors in skeletal muscle regeneration
5. Activation of the interferon system during myogenesis in vitro
6. Interferon production by normal mouse tissues in organ cultures
7. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle
8. Secretion of transcriptional regulation of transforming growth factor-beta 3 during myogenesis
9. Effect of cyclic polylactates on tumor cells and tumor bearing mice
10. Regulation of matrix metalloproteinases and plasminogen activator inhibitor- 1 synthesis by plasminogen in cultured human vascular smooth muscle cells
11. Structure and staining characteristics of myofiber external lamina
12. Cytochemical and physical properties of myofiber external lamina
13. Muscle cells produce a low molecular weight factor with anti-cancer activity
14. Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice
15. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth
16. Structure and function of A1 adenosine receptors
17. Adenosine receptors and beyond: Molecular mechanisms of physiological regulation
18. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptors
19. Adenosine acts as an inhibitor of lymphoma cell growth: A major role for the A3 adenosine receptor
20. Intraskeletal myofiber metastasis of breast carcinoma
21. Intramyofiber metastases in skeletal muscle
22. Tumor cells within skeletal muscle cells
23. Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells
24. Synergistic activation of mitogen-activated protein kinase by cyclic AMP and myeloid growth factors opposes cyclic AMP's growth-inhibitory effects
25. Role of cyclic nucleotides in growth control
26. A3 adenosine receptors: Protective vs. damaging effects identified using novel agonists and antagonists
27. A3 adenosine receptors: Design of selective ligands and therapeutic prospects
28. A3 adenosine receptors: Protective vs. damaging effects identified using novel agonists and antagonists
29. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart
30. Adenosine A3 receptor stimulation and cerebral-ischemia